{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:19:13Z","timestamp":1794071953133,"version":"4.8.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBX009610"],"award-info":[{"award-number":["BBX009610"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Inflamm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons. Although it is traditionally viewed as a neuron-centric disease, neurodegeneration is increasingly linked to immunosenescence and age-related immune dysfunction, but the mechanisms connecting immune ageing to neurodegeneration remain poorly understood. In this review, we explore how metabolic reprogramming, especially the loss of metabolic plasticity in senescent immune cells, drives neuroinflammation in ALS. Senescent immune cells, including microglia and T cells, exhibit mitochondrial dysfunction, redox imbalance, impaired autophagy, and altered nutrient-sensing pathways that impair their homeostatic and reparative capacities. These cells adopt a metabolically demanding pro-inflammatory phenotype, sustaining an inflammatory secretome while promoting glial activation and neuronal damage. Finally, we discuss how targeting immunometabolic pathways may offer new therapeutic opportunities to restore immune balance, mitigate neuroinflammation, and potentially slow ALS progression. Understanding the metabolic basis of immune ageing is essential for developing effective, age-tailored interventions for ALS.<\/jats:p>","DOI":"10.1186\/s12950-025-00460-y","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:00:39Z","timestamp":1756299639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The metabolic intersection between immunosenescence and neuroinflammation in amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Victoria S. K.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian M.","family":"Henson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"1","key":"460_CR1","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primer. 2017;3(1):1\u201319.","journal-title":"Nat Rev Dis Primer"},{"issue":"9769","key":"460_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942\u201355.","journal-title":"Lancet"},{"issue":"3","key":"460_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22(3):185\u2013212.","journal-title":"Nat Rev Drug Discov"},{"key":"460_CR4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10476.1","volume":"6","author":"S Martin","year":"2017","unstructured":"Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Res. 2017;6: 371.","journal-title":"F1000Res"},{"issue":"22","key":"460_CR5","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, et al. Neurofilament light chain. Neurology. 2015;84(22):2247\u201357.","journal-title":"Neurology"},{"key":"460_CR6","unstructured":"Brotman RG, Moreno-Escobar MC, Joseph J, Munakomi S, Pawar G. Amyotrophic Lateral Sclerosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556151\/. Cited 2025 May 12."},{"issue":"5\u20136","key":"460_CR7","first-page":"310","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis. 2009;10(5\u20136):310\u201323.","journal-title":"Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis"},{"issue":"6","key":"460_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","volume":"187","author":"H Ilieva","year":"2009","unstructured":"Ilieva H, Polymenidou M, Cleveland DW. Non\u2013cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187(6):761\u201372.","journal-title":"J Cell Biol"},{"issue":"R2","key":"460_CR9","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1093\/hmg\/ddx247","volume":"26","author":"T Niccoli","year":"2017","unstructured":"Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS\/FTD. Hum Mol Genet. 2017;26(R2):R105\u201313.","journal-title":"Hum Mol Genet"},{"key":"460_CR10","doi-asserted-by":"crossref","unstructured":"Al-Chalabi A, Andrews J, Farhan S. Chapter Two - Recent advances in the genetics of familial and sporadic ALS. In: Shaw PJ, Kirby J, editors. International Review of Neurobiology. Academic Press; 2024. p. 49\u201374. (Motor Neurone Disease; vol. 176). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S007477422400059X. Cited 2025 May 12.","DOI":"10.1016\/bs.irn.2024.04.007"},{"issue":"5","key":"460_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000516752","volume":"55","author":"CA Brown","year":"2021","unstructured":"Brown CA, Lally C, Kupelian V, Flanders WD. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology. 2021;55(5):342\u201353.","journal-title":"Neuroepidemiology"},{"issue":"2","key":"460_CR12","doi-asserted-by":"publisher","first-page":"fcaa124","DOI":"10.1093\/braincomms\/fcaa124","volume":"2","author":"LC B\u00e9land","year":"2020","unstructured":"B\u00e9land LC, Markovinovic A, Jakovac H, De Marchi F, Bilic E, Mazzini L, et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020;2(2):fcaa124.","journal-title":"Brain Commun"},{"issue":"1","key":"460_CR13","doi-asserted-by":"publisher","first-page":"e200042","DOI":"10.1212\/NXI.0000000000200042","volume":"10","author":"O Yildiz","year":"2022","unstructured":"Yildiz O, Schroth J, Tree T, Turner MR, Shaw PJ, Henson SM, et al. Senescent-like blood lymphocytes and disease progression in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation. 2022;10(1):e200042.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"1","key":"460_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0292-2","volume":"13","author":"I Zubiri","year":"2018","unstructured":"Zubiri I, Lombardi V, Bremang M, Mitra V, Nardo G, Adiutori R, et al. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Mol Neurodegener. 2018;13(1): 60.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"460_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28(6):436\u201353.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"460_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8(1):1\u201316.","journal-title":"Signal Transduct Target Ther"},{"key":"460_CR17","doi-asserted-by":"publisher","first-page":"e14548","DOI":"10.1002\/alz.14548","volume":"27","author":"W Elyaman","year":"2025","unstructured":"Elyaman W, Stern LJ, Jiang N, Dressman D, Bradley P, Klatzmann D, et al. Exploring the role of T cells in Alzheimer\u2019s and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium. Alzheimers Dement J Alzheimers Assoc. 2025;27:e14548.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"11","key":"460_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnagi.2019.00042","volume":"28","author":"E Trias","year":"2019","unstructured":"Trias E, Beilby PR, Kovacs M, Ibarburu S, Varela V, Barreto-N\u00fa\u00f1ez R, et al. Emergence of microglia bearing senescence markers during paralysis progression in a rat model of inherited ALS. Front Aging Neurosci. 2019;28(11):42.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"460_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89530","volume":"2","author":"DR Beers","year":"2017","unstructured":"Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2(5): e89530.","journal-title":"JCI Insight"},{"issue":"14","key":"460_CR20","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.neuron.2021.05.020","volume":"109","author":"D Lall","year":"2021","unstructured":"Lall D, Lorenzini I, Mota TA, Bell S, Mahan TE, Ulrich JD, et al. C9orf72 deficiency promotes microglial mediated synaptic loss in aging and amyloid accumulation. Neuron. 2021;109(14):2275-2291.e8.","journal-title":"Neuron"},{"issue":"6","key":"460_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tins.2024.04.003","volume":"47","author":"W Zhang","year":"2024","unstructured":"Zhang W, Sun HS, Wang X, Dumont AS, Liu Q. Cellular senescence, DNA damage, and neuroinflammation in the aging brain. Trends Neurosci. 2024;47(6):461\u201374.","journal-title":"Trends Neurosci"},{"issue":"16","key":"460_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"12","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;12(16): 1347987.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"460_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"460_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):1\u201332.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"460_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener. 2020;15(1):45.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"460_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"AM Blokhuis","year":"2013","unstructured":"Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777\u201394.","journal-title":"Acta Neuropathol"},{"issue":"734","key":"460_CR27","doi-asserted-by":"publisher","first-page":"eadg7162","DOI":"10.1126\/scitranslmed.adg7162","volume":"16","author":"S Seddighi","year":"2024","unstructured":"Seddighi S, Qi YA, Brown AL, Wilkins OG, Bereda C, Belair C, et al. Mis-spliced transcripts generate de novo proteins in TDP-43\u2013related ALS\/FTD. Sci Transl Med. 2024;16(734):eadg7162.","journal-title":"Sci Transl Med"},{"issue":"1","key":"460_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00608-5","volume":"18","author":"PR Mehta","year":"2023","unstructured":"Mehta PR, Brown AL, Ward ME, Fratta P. The era of cryptic exons: implications for ALS-FTD. Mol Neurodegener. 2023;18(1): 16.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"460_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00685-6","volume":"19","author":"KE Irwin","year":"2024","unstructured":"Irwin KE, Sheth U, Wong PC, Gendron TF. Fluid biomarkers for amyotrophic lateral sclerosis: a review. Mol Neurodegener. 2024;19(1): 9.","journal-title":"Mol Neurodegener"},{"key":"460_CR30","unstructured":"Chizari S, Zanovello M, Kong S, Saigal V, Brown AL, Turchetti V, et al. TDP-43 pathology induces CD8+ T cell activation through cryptic epitope recognition. bioRxiv; 2025. p. 2025.06.22.660773. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.06.22.660773v1. Cited 2025 Jul 10."},{"issue":"1","key":"460_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","volume":"52","author":"S Boill\u00e9e","year":"2006","unstructured":"Boill\u00e9e S, Vande Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52(1):39\u201359.","journal-title":"Neuron"},{"key":"460_CR32","doi-asserted-by":"crossref","unstructured":"Evangelista BA, Ragusa JV, Pellegrino K, Wu Y, Quiroga-Barber IY, Cahalan SR, et al. TDP-43 pathology links innate and adaptive immunity in amyotrophic lateral sclerosis. bioRxiv; 2024. p. 2024.01.07.574541. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.01.07.574541v2. Cited 2024 Mar 14.","DOI":"10.1101\/2024.01.07.574541"},{"issue":"21","key":"460_CR33","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8(21):1005.","journal-title":"Front Immunol"},{"issue":"10","key":"460_CR34","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1523\/JNEUROSCI.0998-21.2022","volume":"42","author":"S Mitra","year":"2022","unstructured":"Mitra S, Banik A, Saurabh S, Maulik M, Khatri SN. Neuroimmunometabolism: a new pathological nexus underlying neurodegenerative disorders. J Neurosci. 2022;42(10):1888\u2013907.","journal-title":"J Neurosci"},{"issue":"1","key":"460_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","volume":"31","author":"SH Appel","year":"2010","unstructured":"Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in Parkinson\u2019s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol. 2010;31(1):7\u201317.","journal-title":"Trends Immunol"},{"issue":"2","key":"460_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel JS, Engelhardt JI, Sikl\u00f3s L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55(2):221\u201335.","journal-title":"Ann Neurol"},{"issue":"3","key":"460_CR37","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140(3):691\u2013707.","journal-title":"Am J Pathol"},{"issue":"14","key":"460_CR38","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00018-019-03111-7","volume":"76","author":"M Oksanen","year":"2019","unstructured":"Oksanen M, Lehtonen S, Jaronen M, Goldsteins G, H\u00e4m\u00e4l\u00e4inen RH, Koistinaho J. Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms. Cell Mol Life Sci CMLS. 2019;76(14):2739\u201360.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"10","key":"460_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.molmed.2022.07.003","volume":"28","author":"C Nelke","year":"2022","unstructured":"Nelke C, Schroeter CB, Pawlitzki M, Meuth SG, Ruck T. Cellular senescence in neuroinflammatory disease: new therapies for old cells? Trends Mol Med. 2022;28(10):850\u201363.","journal-title":"Trends Mol Med"},{"key":"460_CR40","doi-asserted-by":"crossref","unstructured":"Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y. Neuroinflammation: Microglia and T Cells Get Ready to Tango. Front Immunol. 2018 Jan 25;8. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2017.01905\/full. Cited 2024 Aug 1.","DOI":"10.3389\/fimmu.2017.01905"},{"issue":"11","key":"460_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2020.00279","volume":"21","author":"PA McCombe","year":"2020","unstructured":"McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020;21(11):279.","journal-title":"Front Neurol"},{"issue":"1","key":"460_CR42","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani S, Seitz C, Cui C, Lovik A, Pan L, Piehl F, et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat Commun. 2022;13(1):6733.","journal-title":"Nat Commun"},{"issue":"1","key":"460_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12916-023-02736-7","volume":"21","author":"B Liu","year":"2023","unstructured":"Liu B, Lyu L, Zhou W, Song J, Ye D, Mao Y, et al. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a mendelian randomization study. BMC Med. 2023;21(1):39.","journal-title":"BMC Med"},{"issue":"9","key":"460_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094402","volume":"22","author":"EK Greenwood","year":"2021","unstructured":"Greenwood EK, Brown DR. Senescent microglia: the key to the ageing brain? Int J Mol Sci. 2021;22(9): 4402.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"460_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505\u201322.","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"460_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576\u201390.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"460_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023;8(1):1\u201329.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"460_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","volume":"120","author":"D Aw","year":"2007","unstructured":"Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;120(4):435\u201346.","journal-title":"Immunology"},{"issue":"1","key":"460_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","volume":"17","author":"R Thomas","year":"2020","unstructured":"Thomas R, Wang W, Su DM. Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing. 2020;17(1):2.","journal-title":"Immun Ageing"},{"issue":"153","key":"460_CR50","doi-asserted-by":"publisher","first-page":"113412","DOI":"10.1016\/j.biopha.2022.113412","volume":"1","author":"Q Wang","year":"2022","unstructured":"Wang Q, Lu M, Zhu X, Gu X, Zhang T, Xia C, et al. The role of microglia immunometabolism in neurodegeneration: focus on molecular determinants and metabolic intermediates of metabolic reprogramming. Biomed Pharmacother. 2022;1(153):113412.","journal-title":"Biomed Pharmacother"},{"issue":"7501","key":"460_CR51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"MJ Van Deursen","year":"2014","unstructured":"Van Deursen MJ. The role of senescent cells in ageing. Nature. 2014;509(7501):439\u201346.","journal-title":"Nature"},{"key":"460_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.coph.2021.01.003","volume":"57","author":"KA Lee","year":"2021","unstructured":"Lee KA, Robbins PD, Camell CD. Intersection of immunometabolism and immunosenescence during aging. Curr Opin Pharmacol. 2021;57:107\u201316.","journal-title":"Curr Opin Pharmacol"},{"key":"460_CR53","doi-asserted-by":"publisher","unstructured":"Saleh Z, Mirzazadeh S, Mirzaei F, Heidarnejad K, Meri S, Kalantar K. Alterations in metabolic pathways: a bridge between aging and weaker innate immune response. Front Aging. 2024 Mar 5;5. Available from: https:\/\/www.frontiersin.org\/journals\/aging\/articles\/https:\/\/doi.org\/10.3389\/fragi.2024.1358330\/full. Cited 2025 Jan 23.","DOI":"10.3389\/fragi.2024.1358330\/full"},{"issue":"1","key":"460_CR54","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin XY, Yu Y, Yuan J, Zhao Y, et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep. 2017;7(1):9094.","journal-title":"Sci Rep"},{"issue":"4","key":"460_CR55","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"CH Lu","year":"2016","unstructured":"Lu CH, Allen K, Oei F, Leoni E, Kuhle J, Tree T, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4): e244.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"460_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2017.05.001","volume":"37","author":"N Michaelson","year":"2017","unstructured":"Michaelson N, Facciponte D, Bradley W, Stommel E. Cytokine expression levels in ALS: a potential link between inflammation and BMAA-triggered protein misfolding. Cytokine Growth Factor Rev. 2017;37:81\u20138.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"460_CR57","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000697","volume":"7","author":"MN Olesen","year":"2020","unstructured":"Olesen MN, Wuolikainen A, Nilsson AC, Wirenfeldt M, Forsberg K, Madsen JS, et al. Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation. 2020;7(3): e697.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"Suppl_1","key":"460_CR58","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser A. 2014;69(Suppl_1):S4-9.","journal-title":"J Gerontol Ser A"},{"issue":"9","key":"460_CR59","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest. 2017;127(9):3250\u20138.","journal-title":"J Clin Invest"},{"issue":"11","key":"460_CR60","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","volume":"7","author":"L Ferraiuolo","year":"2011","unstructured":"Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7(11):616\u201330.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"460_CR61","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","volume":"135","author":"T Vandoorne","year":"2018","unstructured":"Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489\u2013509.","journal-title":"Acta Neuropathol"},{"issue":"21","key":"460_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714742","volume":"12","author":"DE Martin","year":"2021","unstructured":"Martin DE, Torrance BL, Haynes L, Bartley JM. Targeting aging: lessons learned from immunometabolism and cellular senescence. Front Immunol. 2021;12(21): 714742.","journal-title":"Front Immunol"},{"issue":"9","key":"460_CR63","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"460_CR64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott EM, O\u2019Neill LAJ. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 2020;30(4):300\u201314.","journal-title":"Cell Res"},{"key":"460_CR65","unstructured":"Rosina M, Scaricamazza S, Fenili G, Nesci V, Valle C, Ferri A, et al. Hidden players in the metabolic vulnerabilities of amyotrophic lateral sclerosis. Trends Endocrinol Metab. 2025; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S104327602500044X. Cited 2025 Jun 25."},{"issue":"10","key":"460_CR66","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41577-021-00529-8","volume":"21","author":"K Voss","year":"2021","unstructured":"Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. A guide to interrogating immunometabolism. Nat Rev Immunol. 2021;21(10):637\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"460_CR67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-020-00511-2","volume":"11","author":"TW Tefera","year":"2021","unstructured":"Tefera TW, Steyn FJ, Ngo ST, Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target? Cell Biosci. 2021;11(1):14.","journal-title":"Cell Biosci"},{"issue":"6","key":"460_CR68","first-page":"1210","volume":"16","author":"MW Lo","year":"2020","unstructured":"Lo MW, Lee JD. Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis. Neural Regen Res. 2020;16(6):1210\u20131.","journal-title":"Neural Regen Res"},{"issue":"2","key":"460_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2019.03.199","volume":"513","author":"C Chini","year":"2019","unstructured":"Chini C, Hogan KA, Warner GM, Tarrag\u00f3 MG, Peclat TR, Tchkonia T, et al. The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. Biochem Biophys Res Commun. 2019;513(2):486\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"460_CR70","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978\u201390.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"460_CR71","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1172\/JCI75051","volume":"124","author":"SM Henson","year":"2014","unstructured":"Henson SM, Lanna A, Riddell NE, Franzese O, Macaulay R, Griffiths SJ, et al. P38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells. J Clin Invest. 2014;124(9):4004\u201316.","journal-title":"J Clin Invest"},{"issue":"209","key":"460_CR72","doi-asserted-by":"publisher","first-page":"111742","DOI":"10.1016\/j.mad.2022.111742","volume":"1","author":"K Li","year":"2023","unstructured":"Li K, Romero M, Ca\u00f1ardo M, Garcia D, Diaz A, Blomberg BB, et al. B cells from old mice induce the generation of inflammatory T cells through metabolic pathways. Mech Ageing Dev. 2023;1(209):111742.","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"460_CR73","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1111\/acel.13067","volume":"19","author":"LA Callender","year":"2020","unstructured":"Callender LA, Carroll EC, Bober EA, Akbar AN, Solito E, Henson SM. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19(2):e13067.","journal-title":"Aging Cell"},{"issue":"4","key":"460_CR74","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1515\/hsz-2013-0271","volume":"395","author":"V Iacobazzi","year":"2014","unstructured":"Iacobazzi V, Infantino V. Citrate \u2013 new functions for an old metabolite. Biol Chem. 2014;395(4):387\u201399.","journal-title":"Biol Chem"},{"issue":"5","key":"460_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109911","volume":"37","author":"MI Matias","year":"2021","unstructured":"Matias MI, Yong CS, Foroushani A, Goldsmith C, Mongellaz C, Sezgin E, et al. Regulatory t cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep. 2021;37(5): 109911.","journal-title":"Cell Rep"},{"issue":"8","key":"460_CR76","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1038\/s41598-018-29809-5","volume":"14","author":"ENL James","year":"2018","unstructured":"James ENL, Bennett MH, Parkinson EK. The induction of the fibroblast extracellular senescence metabolome is a dynamic process. Sci Rep. 2018;14(8):12148.","journal-title":"Sci Rep"},{"issue":"4","key":"460_CR77","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10555-021-10007-1","volume":"40","author":"EK Parkinson","year":"2021","unstructured":"Parkinson EK, Adamski J, Zahn G, Gaumann A, Flores-Borja F, Ziegler C, et al. Extracellular citrate and metabolic adaptations of cancer cells. Cancer Metastasis Rev. 2021;40(4):1073\u201391.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"460_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","volume":"97","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino M, Carr\u00ec MT. Mitochondrial dysfunction in ALS. Prog Neurobiol. 2012;97(2):54\u201366.","journal-title":"Prog Neurobiol"},{"issue":"4","key":"460_CR79","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41418-020-00664-0","volume":"28","author":"JH Hor","year":"2021","unstructured":"Hor JH, Santosa MM, Lim VJW, Ho BX, Taylor A, Khong ZJ, et al. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death Differ. 2021;28(4):1379\u201397.","journal-title":"Cell Death Differ"},{"issue":"2","key":"460_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s40142-017-0123-8","volume":"5","author":"A Joardar","year":"2017","unstructured":"Joardar A, Manzo E, Zarnescu DC. Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities. Curr Genet Med Rep. 2017;5(2):108\u201314.","journal-title":"Curr Genet Med Rep"},{"issue":"8","key":"460_CR81","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869\u201378.","journal-title":"Nat Med"},{"issue":"3","key":"460_CR82","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.032539299","volume":"99","author":"DS Howland","year":"2002","unstructured":"Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A. 2002;99(3):1604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7408","key":"460_CR83","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 2012;487(7408):443\u20138.","journal-title":"Nature"},{"issue":"1","key":"460_CR84","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1471-4159.2007.04531.x","volume":"102","author":"SA Ezzi","year":"2007","unstructured":"Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102(1):170\u20138.","journal-title":"J Neurochem"},{"issue":"2","key":"460_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/glia.20919","volume":"58","author":"W Zhao","year":"2010","unstructured":"Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010;58(2):231\u201343.","journal-title":"Glia"},{"issue":"273","key":"460_CR86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","volume":"1","author":"W Zhao","year":"2015","unstructured":"Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, et al. TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome. Exp Neurol. 2015;1(273):24\u201335.","journal-title":"Exp Neurol"},{"issue":"3","key":"460_CR87","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/glia.22444","volume":"61","author":"K Roberts","year":"2013","unstructured":"Roberts K, Zeineddine R, Corcoran L, Li W, Campbell IL, Yerbury JJ. Extracellular aggregated Cu\/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia. 2013;61(3):409\u201319.","journal-title":"Glia"},{"issue":"2","key":"460_CR88","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bpa.12352","volume":"26","author":"F Puentes","year":"2016","unstructured":"Puentes F, Malaspina A, van Noort JM, Amor S. Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers. Brain Pathol. 2016;26(2):248\u201357.","journal-title":"Brain Pathol"},{"issue":"1","key":"460_CR89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 2012;237(1):147\u201352.","journal-title":"Exp Neurol"},{"issue":"20","key":"460_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00402-3","volume":"13","author":"C Rim","year":"2024","unstructured":"Rim C, You MJ, Nahm M, Kwon MS. Emerging role of senescent microglia in brain aging-related neurodegenerative diseases. Transl Neurodegener. 2024;13(20): 10.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"460_CR91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12974-022-02421-1","volume":"19","author":"H Quek","year":"2022","unstructured":"Quek H, Cun\u00ed-L\u00f3pez C, Stewart R, Colletti T, Notaro A, Nguyen TH, et al. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. J Neuroinflammation. 2022;19(1):58.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"460_CR92","doi-asserted-by":"publisher","first-page":"105614","DOI":"10.1016\/j.neuint.2023.105614","volume":"171","author":"H Chen","year":"2023","unstructured":"Chen H, Guo Z, Sun Y, Dai X. The immunometabolic reprogramming of microglia in Alzheimer\u02bcs disease. Neurochem Int. 2023;171(1):105614.","journal-title":"Neurochem Int"},{"issue":"12","key":"460_CR93","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1021\/acschemneuro.8b00334","volume":"9","author":"DM Angelova","year":"2018","unstructured":"Angelova DM, Brown DR. Altered processing of \u03b2-amyloid in SH-SY5Y cells induced by model senescent microglia. ACS Chem Neurosci. 2018;9(12):3137\u201352.","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"460_CR94","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","volume":"44","author":"A Guerrero","year":"2021","unstructured":"Guerrero A, Strooper BD, Arancibia-C\u00e1rcamo IL. Cellular senescence at the crossroads of inflammation and Alzheimer\u2019s disease. Trends Neurosci. 2021;44(9):714\u201327.","journal-title":"Trends Neurosci"},{"issue":"6","key":"460_CR95","first-page":"7225","volume":"34","author":"TS McDonald","year":"2020","unstructured":"McDonald TS, McCombe PA, Woodruff TM, Lee JD. The potential interplay between energy metabolism and innate complement activation in amyotrophic lateral sclerosis. FASEB J Off Publ Fed Am Soc Exp Biol. 2020;34(6):7225\u201333.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"68","key":"460_CR96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2017.10.017","volume":"1","author":"R Holland","year":"2018","unstructured":"Holland R, McIntosh AL, Finucane OM, Mela V, Rubio-Araiz A, Timmons G, et al. Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP\/PS1 mice. Brain Behav Immun. 2018;1(68):183\u201396.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"460_CR97","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bpa.12704","volume":"29","author":"A McIntosh","year":"2019","unstructured":"McIntosh A, Mela V, Harty C, Minogue AM, Costello DA, Kerskens C, et al. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP\/PS1 mice. Brain Pathol. 2019;29(5):606\u201321.","journal-title":"Brain Pathol"},{"issue":"7","key":"460_CR98","doi-asserted-by":"publisher","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","volume":"12","author":"MP Gustafson","year":"2017","unstructured":"Gustafson MP, Staff NP, Bornschlegl S, Butler GW, Maas ML, Kazamel M, et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLoS One. 2017;12(7):e0182002.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"460_CR99","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","volume":"276","author":"S Mantovani","year":"2014","unstructured":"Mantovani S, Gordon R, Macmaw JK, Pfluger CMM, Henderson RD, Noakes PG, et al. Elevation of the terminal complement activation products C5a and C5b\u20139 in ALS patient blood. J Neuroimmunol. 2014;276(1\u20132):213\u20138.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"460_CR100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12974-023-03007-1","volume":"21","author":"S Zaccai","year":"2024","unstructured":"Zaccai S, Nemirovsky A, Lerner L, Alfahel L, Eremenko E, Israelson A, et al. CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2024;21(1):17.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"460_CR101","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.jcyt.2016.06.012","volume":"18","author":"A Alsuliman","year":"2016","unstructured":"Alsuliman A, Appel SH, Beers DR, Basar R, Shaim H, Kaur I, et al. A robust, good manufacturing practice\u2013compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy. Cytotherapy. 2016;18(10):1312\u201324.","journal-title":"Cytotherapy"},{"issue":"4","key":"460_CR102","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000465","volume":"5","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, et al. Expanded autologous regulatory T-lymphocyte infusions in ALS. Neurol Neuroimmunol Neuroinflamm. 2018;5(4): e465.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10492","key":"460_CR103","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(25)00262-4","volume":"405","author":"G Bensimon","year":"2025","unstructured":"Bensimon G, Leigh PN, Tree T, Malaspina A, Payan CA, Pham HP, et al. Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial. Lancet. 2025;405(10492):1837\u201350.","journal-title":"Lancet"},{"issue":"16","key":"460_CR104","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","volume":"28","author":"P Cassina","year":"2008","unstructured":"Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Le\u00f3n A, et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008;28(16):4115\u201322.","journal-title":"J Neurosci"},{"issue":"7728","key":"460_CR105","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian TJ, Aziz A, Meyer CF, Swenson BL, van Deursen JM, Baker DJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature. 2018;562(7728):578\u201382.","journal-title":"Nature"},{"issue":"2","key":"460_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13296","volume":"20","author":"M Ogrodnik","year":"2021","unstructured":"Ogrodnik M, Evans SA, Fielder E, Victorelli S, Kruger P, Salmonowicz H, et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell. 2021;20(2): e13296.","journal-title":"Aging Cell"}],"container-title":["Journal of Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12950-025-00460-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12950-025-00460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:20:56Z","timestamp":1781608856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12950-025-00460-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s12950-025-00460-y","relation":{},"ISSN":["1476-9255"],"issn-type":[{"value":"1476-9255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}